Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, today announced it has been named a leader in the Frost Radar™ Report for Antibody-Drug Conjugate Contract ...

Lonza plans to increase bioconjugation capacity for the production of antibody drug conjugates (ADCs) by 300% with the addition of two commercial-scale bioconjugation suites at its manufacturing site ...

Bioconjugation capability will complement commercial payload, linker and monoclonal antibodies services The OEB-5 rated suite will accelerate ADC development timelines by enabling both Monoclonal ...

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical raw materials to the life science industry, is pleased to announce today that it has acquired celares, a leader in the development ...

The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply. STAAD, ...

The global bioconjugation market is projected to grow at an estimated CAGR of close to 13% over the next five years. This growth is fueled by the rising need for targeted therapies, continuous ...

What are the critical factors to bioconjugation success? Explore the workflow and learn how you can get started with quantitative and reproducible bioconjugation. SoluLINK bioconjugation technology ...

ADC Biotechnology, a Welsh company specializing in antibody-drug conjugate (ADC) contract services, said it will invest $11 million to build a new facility in Deeside, North Wales. The ...

Bioconjugation is a critical technique for creating many of the key reagents used in research and commercial applications. This webinar will cover in great detail the major reactions used to form ...

Biomacromolecules, including proteins, enzymes, and antibodies, are the workhorses of living systems and the foundation of breakthrough technologies in medicine, energy, sustainability, and food ...

Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru.